Objective To examine region‐ and substrate‐specific autoradiographic and in vitro binding
patterns of positron emission tomography tracer [F‐18]‐AV‐1451 (previously known as T807)…

Importance One characteristic histopathological event in Alzheimer disease (AD) is cerebral
amyloid aggregation, which can be detected by biomarkers in cerebrospinal fluid (CSF) and …

The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has rapidly spread worldwide and has had unprecedented …

Objective Recent studies have shown that positron emission tomography (PET) tracer AV‐1451
exhibits high binding affinity for paired helical filament (PHF)‐tau pathology in …

Background Dementia in Parkinson disease (PD) causes nursing home placement, caregiver
distress, higher health care burden, and increased mortality. Objective To determine …

Increasing life expectancy has led to an aging population, which has consequently increased
the prevalence of dementia. Alzheimer's disease (AD), the most common form of dementia …

Amyloid-beta 42 (Aβ42) and phosphorylated tau (pTau) levels in cerebrospinal fluid (CSF)
reflect core features of the pathogenesis of Alzheimer’s disease (AD) more directly than …

… Marta Marquié … Marta Ibarria …

[F-18]-AV-1451 is a novel positron emission tomography (PET) tracer with high affinity to
neurofibrillary tau pathology in Alzheimer’s disease (AD). PET studies have shown increased …

Neuropsychiatric symptoms (NPS) have been recently addressed as risk factors of conversion
to Alzheimer’s disease (AD) and other dementia types in patients diagnosed with Mild …